Discovery of Streptomyces species CS-62, a novel producer of the Acinetobacter baumannii selective antibiotic factumycin
- PMID: 38632045
- PMCID: PMC11066910
- DOI: 10.1093/jimb/kuae014
Discovery of Streptomyces species CS-62, a novel producer of the Acinetobacter baumannii selective antibiotic factumycin
Abstract
Narrow-spectrum antibiotics are of great interest given their ability to spare the microbiome and decrease widespread antibiotic resistance compared to broad-spectrum antibiotics. Herein, we screened an in-house library of Actinobacteria strains for selective activity against Acinetobacter baumannii and successfully identified Streptomyces sp. CS-62 as a producer of a natural product with this valuable activity. Analysis of the cultures via high-resolution mass spectrometry and tandem mass spectrometry, followed by comparison with molecules in the Natural Product Atlas and the Global Natural Products Social Molecular Networking platform, suggested a novel natural product. Genome mining analysis initially supported the production of a novel kirromycin derivative. Isolation and structure elucidation via mass spectrometry and Nuclear Magnetic Resonance (NMR) analyses revealed that the active natural product was the known natural product factumycin, exposing omissions and errors in the consulted databases. While public databases are generally very useful for avoiding rediscovery of known molecules, rediscovery remains a problem due to public databases either being incomplete or having errors that result in failed dereplication. Overall, the work describes the ongoing problem of dereplication and the continued need for public database curation.
Keywords: Antibiotics; Biosynthetic gene cluster; Dereplication; Natural products.
© The Author(s) 2024. Published by Oxford University Press on behalf of Society of Industrial Microbiology and Biotechnology.
Conflict of interest statement
The authors report no conflicts of interest.
Figures




Similar articles
-
The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory clpP Gene as a Novel Antibiotic Resistance Factor.Appl Environ Microbiol. 2019 Oct 1;85(20):e01292-19. doi: 10.1128/AEM.01292-19. Print 2019 Oct 15. Appl Environ Microbiol. 2019. PMID: 31399403 Free PMC article.
-
Identification of Streptomyces sp. KH29, which produces an antibiotic substance processing an inhibitory activity against multidrug-resistant Acinetobacter baumannii.J Microbiol Biotechnol. 2010 Dec;20(12):1672-6. J Microbiol Biotechnol. 2010. PMID: 21193822
-
Investigation on taxonomy, secondary metabolites and antibacterial activity of Streptomyces sediminicola sp. nov., a novel marine sediment-derived Actinobacteria.Microb Cell Fact. 2024 Oct 19;23(1):285. doi: 10.1186/s12934-024-02558-z. Microb Cell Fact. 2024. PMID: 39427194 Free PMC article.
-
Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x. Folia Histochem Cytobiol. 2008. PMID: 19056528 Review.
-
N-Acetyl-Cysteinylated Streptophenazines from Streptomyces.J Nat Prod. 2022 May 27;85(5):1239-1247. doi: 10.1021/acs.jnatprod.1c01123. Epub 2022 Apr 14. J Nat Prod. 2022. PMID: 35422124 Free PMC article. Review.
Cited by
-
Synthetic-bioinformatic natural product-inspired peptides.Nat Prod Rep. 2025 Jan 22;42(1):50-66. doi: 10.1039/d4np00043a. Nat Prod Rep. 2025. PMID: 39479929 Free PMC article. Review.
References
-
- Corey B. W., Thompson M. G., Hittle L. E., Jacobs A. C., Asafo-Adjei E. A., Huggins W. M., Melander R. J., Melander C., Ernst R. K., Zurawski D. V. (2017). 1,2,4-Triazolidine-3-thiones have specific activity against Acinetobacter baumannii among common nosocomial pathogens. ACS Infectious Diseases, 3(1), 62–71. 10.1021/ACSINFECDIS.6B00133/ASSET/IMAGES/LARGE/ID-2016-00133W_0006.JPEG - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical